CHINA RESOURCES BOYA BIO-PHARMACEUTICAL GROUP CO.,LTD

China Resources Boya Bio-pharmaceutical Group Co.,Ltd

300294

CNE100001FF1

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 17/07/2024 am IST			5-day change	1st Jan Change
35.67 ^CNY	+0.85%		+2.74%	+5.91%

27/05	Morgan Stanley Starts China Resources Boya Bio-pharmaceutical Group at Equal-weight; Price Target is 37 Yuan	MT
23/04	China Resources Boya Bio-pharmaceutical Group Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Boya Bio-pharmaceutical Group Co., Ltd.(SZSE:300294) added to Shenzhen Stock Exchange Component Index

January 04, 2017 at 10:30 am IST

Jiangxi Boya Bio-Pharmaceutical Co., Ltd has been added to Shenzhen Stock Exchange Component Index.

Latest news about China Resources Boya Bio-pharmaceutical Group Co.,Ltd

Morgan Stanley Starts China Resources Boya Bio-pharmaceutical Group at Equal-weight; Price Target is 37 Yuan	27/05	MT
China Resources Boya Bio-pharmaceutical Group Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	23/04	CI
China Resources Boya Bio-Pharmaceutical Group Co.,Ltd. Approves Cash Dividend for the Year 2023	16/04	CI
China Resources Boya Bio-Pharmaceutical Group Co.,Ltd Proposes Cash Dividend	25/03	CI
CR Boya Bio-Pharmaceutical's 2023 Profit Falls on Lower Revenue	14/03	MT
China Resources Boya Bio-pharmaceutical Group Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	13/03	CI
CR Boya Bio-Pharmaceutical Signs 29.5 Million Yuan Construction Contract for Blood Products Facility	06/02	MT
China Resources Double-Crane Pharmaceutical Co.,Ltd. completed the acqyusution 89.681% stake in Guizhou Tianan Pharmaceutical Company from Jiangxi Boya Pharmaceutical Investment Co., Ltd and China Resources Boya Bio-pharmaceutical Group Co.,Ltd.	03/11	CI
CR Boya Bio-Pharmaceutical's January-September Profit Increases	26/23/26	MT
China Resources Boya Bio-pharmaceutical Group Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	25/23/25	CI
China Resources Double-Crane Pharmaceutical Co.,Ltd. agreed to acquire an 89.681% stake in Guizhou Tianan Pharmaceutical Company from Jiangxi Boya Pharmaceutical Investment Co., Ltd and China Resources Boya Bio-pharmaceutical Group Co.,Ltd for CNY 260 million	28/23/28	CI
China Resources Pharmaceutical Commercial Group Company Limited completed the acquisition of 75% stake in Guangdong Fuda Pharmaceutical Co., Ltd. from China Resources Boya Bio-pharmaceutical Group Co., Ltd..	25/23/25	CI
China Resources Pharmaceutical Commercial Group Company Limited agreed to acquire 75% stake in Guangdong Fuda Pharmaceutical Co., Ltd. from China Resources Boya Bio-pharmaceutical Group Co., Ltd. for approximately CNY 360 million.	30/23/30	CI
China Resources Pharmaceutical's Subsidiaries Log Increases in H1 Profits	25/23/25	MT
China Resources Boya's H1 Attributable Profit Jumps 16.9%	22/23/22	MT
China Resources Boya Bio-pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	21/23/21	CI
China Resources Boya Bio-pharmaceutical Group's Q1 Profit Rises	25/23/25	MT
China Resources Boya Bio-pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	24/23/24	CI
China Resources Boya Bio-pharmaceutical Group Co., Ltd. Approves Cash Dividend for 2022, Payable on 28 April 2023	18/23/18	CI
CR Boya Bio-pharmaceutical Estimates Higher Q1 Profit	11/23/11	MT
China Resources Boya Bio-Pharmaceutical Group Co., Ltd. Proposes Dividend for the Year 2022	27/23/27	CI
China Resources Boya Bio-pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	12/23/12	CI
CR Boya Bio-pharmaceutical's January-September Profit Rises	25/22/25	MT
China Resources Boya Bio-pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	24/22/24	CI
China Resources Boya Bio-pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	19/22/19	CI

Chart China Resources Boya Bio-pharmaceutical Group Co.,Ltd

Duration

Period

Chart China Resources Boya Bio-pharmaceutical Group Co.,Ltd

More charts

China Resources Boya Bio pharmaceutical Group Co Ltd is a China-based company principally engaged in the research, development, production and distribution of blood products. The Company mainly operates its business through five segments. The Blood Products Business segment mainly engages in the research and development, production and sales of blood products including albumin series, immunoglobulins series and coagulation factors series products. The Diabetes Medicine Business segment engages in the production and sales of diabetes and other categories of medicine. The Biochemical Pharmaceutical Business segment engages in the research and development, production and sales of biochemical medicine. The Pharmaceutical Distribution Business segment engages in the pharmaceutical distribution business. The Other Business segment engages in biotechnology development and other businesses. The Company conducts its business in the domestic market.

Sector

Pharmaceuticals

Calendar

24/08/2024 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for China Resources Boya Bio-pharmaceutical Group Co.,Ltd

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

35.67 CNY

Average target price

34.22 CNY

Spread / Average Target

-4.06%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Biopharmaceuticals

	1st Jan change	Capi.
CHINA RESOURCES BOYA BIO-PHARMACEUTICAL GROUP CO.,LTD	+5.91%	2.46B
CSL LIMITED	+8.04%	100B
SAMSUNG BIOLOGICS CO.,LTD.	+11.97%	42.34B
BIOGEN INC.	-11.76%	32.76B
UCB	+79.34%	29.46B
BIOMARIN PHARMACEUTICAL INC.	-12.20%	16.31B
INCYTE CORPORATION	+4.00%	14.39B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-1.90%	12.23B
ALTEOGEN INC.	+178.17%	10.47B
SWEDISH ORPHAN BIOVITRUM AB	+1.80%	8.97B

Biopharmaceuticals

China Resources Boya Bio-pharmaceutical Group Co.,Ltd

Equities

300294

CNE100001FF1

Pharmaceuticals

Boya Bio-pharmaceutical Group Co., Ltd.(SZSE:300294) added to Shenzhen Stock Exchange Component Index

Latest news about China Resources Boya Bio-pharmaceutical Group Co.,Ltd

Chart China Resources Boya Bio-pharmaceutical Group Co.,Ltd

Company Profile

Income Statement Evolution

Ratings for China Resources Boya Bio-pharmaceutical Group Co.,Ltd

Analysts' Consensus

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Biopharmaceuticals